AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3349861
Drug: Chloramphenicol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol (500 mg orally every 6 h)
Trial: 12531578
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (losartan 100 mg daily + trandolapril 3 mg daily)
Trial: 12531578
Drug: Trandolapril alone
RxNorm normalized name: Trandolapril
DrugBank: Trandolapril (DB00519)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trandolapril alone (3 mg daily)
Trial: 12531578
Drug: Losartan alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan alone (100 mg daily)
Trial: 10233213
Drug: Ticlopidine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (300 mg daily for 6 days)
Trial: 8729142
Drug: n-3 fatty
RxNorm normalized name: n-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 fatty acid capsules (9 g/d)
Trial: 8729142
Drug: Placebo capsules
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo capsules (9 g/d)
Trial: 30235716
Drug: Esketamine (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esketamine (0.25 mg/kg)
Trial: 28212067
Drug: PT+stimulant+risperidone (Augmented)
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: PT+stimulant+risperidone (Augmented)
Trial: 28212067
Drug: PT+stimulant+placebo (Basic)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PT+stimulant+placebo (Basic)
Trial: 22798186
Drug: Stapled or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stapled or sutured closure plus falciform ligament patch and fibrin glue (FF)
Trial: 17622258
Drug: 343 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 343 microg [6S]‐5‐CH(3)H(4)PteGlu with 289.4 mg L‐AA
Trial: 17622258
Drug: 343 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 343 microg [6S]‐5‐CH(3)H(4)PteGlu with 973.8 mg L‐AA
Trial: 16929983
Drug: Autologous bone
RxNorm normalized name: Human autologous bone marrow derived osteoblastic cells
DrugBank: Human autologous bone marrow derived osteoblastic cells (DB18259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous bone marrow mononuclear cells transplanted by intracoronary infusion
Trial: 16929983
Drug: Traditional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional therapy alone (Control)
Trial: 16929983
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of bone marrow mononuclear cells
Trial: 1653662
Drug: Beta-hydroxybutyrate (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-hydroxybutyrate (3 mg min-1 kg-1 body weight)
Trial: 6837082
Drug: Cold Air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold Air Inhalation Test (CAIT)
Trial: 3768639
Drug: Domperidone 8
RxNorm normalized name: Domperidone
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone 8 mg intravenously with standard barium sulphate preparation
Trial: 3768639
Drug: Metoclopramide 10
RxNorm normalized name: metoclopramide 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 10 mg intravenously with standard barium sulphate preparation
Trial: 29420050
Drug: Mobile mindfulness
RxNorm normalized name: Chamaemelum nobile extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobile mindfulness meditation using the Headspace application for 30 days (10-20 minutes daily)
Trial: 22689092
Drug: A +
RxNorm normalized name: Vital E- A + D3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: A + T (adjuvant anthracycline and taxane chemotherapy)
Trial: 1867428
Drug: Nicardipine (1‐3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine (1‐3 micrograms.kg‐1.min‐1, after a titration dose of 4.7 +/‐ 1.5 mg)
Trial: 6297380
Drug: Topical enviroxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical enviroxime nasal spray
Trial: 30358417
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg daily for 1 month)
Trial: 30358417
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (75 IU daily for 1 month)
Trial: 25346896
Drug: Midazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1 mg bolus and 0.1 mg/kg/hr, n=30)
Trial: 25346896
Drug: Propofol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (20 mg bolus and 0.1 mg/kg/hr, n=30)
Trial: 22052885
Drug: AmB (0.7-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB (0.7-1 mg/kg) and 5-FC (25 mg/kg 4 times daily)
Trial: 22052885
Drug: AmB (0.7-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB (0.7-1 mg/kg) and fluconazole (800 mg daily)
Trial: 22052885
Drug: AmB (0.7-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB (0.7-1 mg/kg) and fluconazole (600 mg twice daily)
Trial: 22052885
Drug: AmB (0.7-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmB (0.7-1 mg/kg) and voriconazole (300 mg twice daily)
Trial: 11408002
Drug: Insulin-dependent diabetic
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetic patients with nephropathy
Trial: 11408002
Drug: Insulin-dependent diabetic
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetic patients without nephropathy
Trial: 11408002
Drug: Insulin-dependent diabetic
RxNorm normalized name: Diabetic Tussin EX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-dependent diabetic patients with retinopathy
Trial: 9439085
Drug: Naratriptan 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naratriptan 0.25 mg
Trial: 9409334
Drug: Naratriptan 2.5
RxNorm normalized name: naratriptan 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naratriptan 2.5 mg and 1 mg
Trial: 8202976
Drug: Control (same
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (same physiotherapy and occupational therapy)
Trial: 28432049
Drug: Swallowed aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Swallowed aspirin taken simultaneously with niacin
Trial: 28432049
Drug: Orally dissolved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally dissolved aspirin taken simultaneously with niacin
Trial: 28432049
Drug: Both orally
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both orally dissolved and swallowed aspirin taken simultaneously with niacin
Trial: 20880286
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg bee pollen/kg BW
Trial: 20880286
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg bee pollen/kg BW
Trial: 20880286
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg bee pollen/kg BW
Trial: 20880286
Drug: Control (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (0 mg bee pollen/kg BW)
Trial: 19660800
Drug: Zuidex (mid-urethral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zuidex (mid-urethral injection)
Trial: 19660800
Drug: Contigen (proximal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contigen (proximal urethral cystoscopic injection)
Trial: 14759446
Drug: HSD solution
RxNorm normalized name: HSD-016
DrugBank: HSD-016 (DB12419)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HSD solution (4 mL/kg during 20 minutes before cardiopulmonary bypass)
Trial: 14759446
Drug: Ringer solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer solution (same volume as HSD)
Trial: 11726445
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered using TCI at target concentrations of 1.5-4.5 microg/mL to pregnant women.
Trial: 11726445
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered using TCI at target concentrations of 1.5-4.5 microg/mL to nonpregnant women.
Trial: 3664551
Drug: Lotion (pyrethrin-piperonyl-butoxide)
RxNorm normalized name: Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lotion (pyrethrin-piperonyl-butoxide)
Trial: 26424673
Drug: Ritonavir-boosted darunavir
RxNorm normalized name: Darunavir
DrugBank: Darunavir (DB01264)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir-boosted darunavir 800 mg plus ritonavir 100 mg
Trial: 22895370
Drug: 30G +
RxNorm normalized name: Insulin glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 30G + MOD (30 g of glucose preexercise)
Trial: 22895370
Drug: 0G +
RxNorm normalized name: Oxycodone and Gabapentin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0G + MOD (0 g of glucose preexercise)
Trial: 22895370
Drug: 0G +
RxNorm normalized name: Oxycodone and Gabapentin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0G + MOD/INT (0 g of glucose preexercise with high-intensity intervals)
Trial: 12872052
Drug: Hydrochlorothiazide (low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (low-dose diuretic)
Trial: 12872052
Drug: Candesartan (angiotensin-II-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (angiotensin-II-receptor blocker)
Trial: 31851795
Drug: Anifrolumab (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anifrolumab (300 mg) every 4 weeks for 48 weeks
Trial: 31234927
Drug: Pertuzumab plus
RxNorm normalized name: Pertuzumab
DrugBank: Pertuzumab (DB06366)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Pertuzumab plus trastuzumab and chemotherapy (n=82)
Trial: 31234927
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus trastuzumab and chemotherapy (control group; n=81)
Trial: 27796604
Drug: Real tDCS
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real tDCS plus occupational therapy
Trial: 27796604
Drug: Sham tDCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham tDCS plus occupational therapy
Trial: 19615959
Drug: Probiotic dairy
RxNorm normalized name: Beano Dairy Defense
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic dairy drink containing Lactobacillus casei DN-114 001 and yoghurt ferments (Actimel), consumed twice daily for 7 weeks (pilot) or 13 weeks (confirmatory).
Trial: 19615959
Drug: Non-fermented control
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-fermented control dairy product, consumed twice daily for 7 weeks (pilot) or 13 weeks (confirmatory).
Trial: 12665918
Drug: Lamivudine 100
RxNorm normalized name: lamivudine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamivudine 100 mg once a day for one year
Trial: 12665918
Drug: Common liver
RxNorm normalized name: LIVER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Common liver protection drugs
Trial: 9699124
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 0.1 IU/Kg i.m. for 3 days
Trial: 1683503
Drug: Quinagolide 0.05
RxNorm normalized name: quinagolide 0.05 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinagolide 0.05 mg
Trial: 1683503
Drug: Quinagolide (incremental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinagolide (incremental doses for 6 months)
Trial: 1683503
Drug: Bromocriptine (incremental
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (incremental doses for 6 months)
Trial: 30218226
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instructions including the use of tongue scraper
Trial: 30218226
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instructions alone without tongue cleaning
Trial: 25784519
Drug: Colchicine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (0.5 mg twice daily for 8 days starting 48 hours before surgery)
Trial: 19137320
Drug: 0.1% ISMN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% ISMN gel
Trial: 19137320
Drug: 0.1% GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% GTN gel
Trial: 14995003
Drug: Intravenous cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cyclophosphamide (IVCYC) 0.5 g/m² body surface area, monthly
Trial: 14995003
Drug: Oral enalapril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral enalapril 10 mg/day
Trial: 11483846
Drug: Omalizumab (0.016
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omalizumab (0.016 mg/kg/IgE [IU/mL] per 4 weeks)
Trial: 9608348
Drug: Frequent take-home
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Frequent take-home medication doses during baseline (8-week duration)
Trial: 9608348
Drug: Fluoxetine 40
RxNorm normalized name: fluoxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 40 mg take-home doses during contingency management
Trial: 9608348
Drug: Fluoxetine 0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 0 mg and 20 mg take-home doses during contingency management
Trial: 8107741
Drug: Interferon alfa-2a
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2a (1.5 million units thrice weekly for 1 week, then 3 million units thrice weekly for 23 weeks)
Trial: 8107741
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no additional treatment apart from previously prescribed treatments)
Trial: 8107741
Drug: Interferon alfa-2a
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2a (resumption of treatment)
Trial: 30822358
Drug: Biologic therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biologic therapies (ustekinumab) in RCTs
Trial: 30822358
Drug: Real-world populations
RxNorm normalized name: REAL FOODS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real-world populations on biologic therapies
Trial: 26700981
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (two 200-μg tablets every 4 hours for up to 48 hours)
Trial: 26700981
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (two 200-μg tablets inserted every 4 hours for 48 hours)
Trial: 26700981
Drug: Combination route
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination route (two 200-μg tablets vaginally followed by 400 μg sublingually every 4 hours for 48 hours)
Trial: 23389691
Drug: GABAA receptors
RxNorm normalized name: Toll-like receptor 9
DrugBank: Toll-like receptor 9 (DB15320)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GABAA receptors in vmPFC and sensorimotor cortex
Trial: 21848959
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g of pure ethanol/kg of body weight (low dose: LD)
Trial: 21848959
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g of pure ethanol/kg of body weight (high dose: HD)
Trial: 21848959
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of pure ethanol/kg of body weight (control)
Trial: 14735686
Drug: Schedule A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule A (weekly)
Trial: 14735686
Drug: Schedule B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule B (twice weekly for 2 weeks repeated every 21 days)
Trial: 14735686
Drug: Schedule C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schedule C (twice weekly every other week)
Trial: 4025164
Drug: FDP (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDP (250 mg/kg body weight in isotonic saline solution intravenously in 20 minutes)
Trial: 23721512
Drug: Cladribine-based combinations
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine-based combinations (CMC: 2-CdA, cyclophosphamide, mitoxantrone; CC: 2-CdA, cyclophosphamide)
Trial: 23721512
Drug: 2-CdA monotherapy
RxNorm normalized name: 2-CdA
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 2-CdA monotherapy
Trial: 23721512
Drug: Cladribine-based combinations
RxNorm normalized name: Cladribine
DrugBank: Cladribine (DB00242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cladribine-based combinations (CMC, CC)
Trial: 12045171
Drug: roxithromycin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin (300 mg daily) for 28 days
Trial: 7710412
Drug: Myo device,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myo device, chewed for four minutes, twice daily
Trial: 7710412
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (customary oral hygiene procedures only)
Trial: 2632755
Drug: Dialysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis with a 'low-calcium' dialysate (1.50 mmol/l)
Trial: 2632755
Drug: Dialysis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dialysis with a 'high-calcium' dialysate (1.75 mmol/l)
Trial: 27031376
Drug: Spectral CT
RxNorm normalized name: Sentinel Spectrum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spectral CT with 350 mgI kg(-1) contrast injection
Trial: 25910889
Drug: Laryngoscopy (L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laryngoscopy (L group)
Trial: 21087825
Drug: Intravenous arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous arginine (30 g for 5 days)
Trial: 21087825
Drug: Placebo (25.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (25.2 g of alanine for 5 days)
Trial: 18503398
Drug: Warfarin 5.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 5.75 mg once/day (uniform dosage)
Trial: 18503398
Drug: Warfarin 7.5
RxNorm normalized name: warfarin 7.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin 7.5 mg/day on Mondays and Fridays and 5 mg/day on each of the remaining days (nonuniform dosage)
Trial: 10699472
Drug: Advice not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advice not to wash hair during treatment (group 1)
Trial: 9336364
Drug: 125 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg/m2 IDEC-C2B8
Trial: 9336364
Drug: 250 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/m2 IDEC-C2B8
Trial: 9336364
Drug: 375 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg/m2 IDEC-C2B8
Trial: 8186669
Drug: Outpatient treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient treatments for marijuana dependence
Trial: 3533670
Drug: Metformin (850
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (850 mg, t.d.)
Trial: 24531025
Drug: Macular laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macular laser therapy
Trial: 19404953
Drug: Low-dose prednisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisone
Trial: 19404953
Drug: High-dose prednisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose prednisone
Trial: 21033120
Drug: Systemic red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic red light therapy, once a day, 30 minutes until wounds recovered.
Trial: 21033120
Drug: Routine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine therapy (Control group)
Trial: 21033120
Drug: Systemic red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic red light therapy
Trial: 7681894
Drug: Dipyridamole (PDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (PDE inhibitor)
Trial: 7681894
Drug: Glyceryl trinitrate
RxNorm normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glyceryl trinitrate (GTN) patches, 10 mg/24 h
Trial: 26420590
Drug: Calcium supplements
RxNorm normalized name: CALCIUM SUPPLEMENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplements (1 g/d)
Trial: 23743397
Drug: Acetaminophen (APAP),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (APAP), 1,000 mg
Trial: 21649830
Drug: Home-use hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-use hydrogen peroxide bleaching agents (PolaDay 7.5%, PolaDay 9.5%, DayWhite ACP-7.5%, DayWhite ACP 9.5%) and in-office agents (PolaOffice 35%, Opalescence XtraBoost 38%) applied for 30 minutes/day for 21 days or in one session a week for 3 weeks.
Trial: 20001836
Drug: Ping On
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ping On ointment